
Assertio Holdings ASRT
€ 10.32
4.88%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Assertio Holdings P/S 2011-2026 | ASRT
P/S Jährlich Assertio Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.434 | 1.78 | 0.894 | 0.621 | 0.336 | 0.898 | 1.22 | 2.38 | 2.69 | 2.73 | 5.09 | 4.06 | 2.49 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.09 | 0.336 | 1.97 |
P/S anderer Aktien in der Arzneimittelhersteller
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 1.14 | -4.62 % | $ 123 M | ||
|
Cronos Group
CRON
|
77.6 | $ 2.56 | 1.24 % | $ 1.35 B | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 4.74 | 1.94 % | $ 66.6 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 11.08 | 0.82 % | $ 567 M | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Evolus
EOLS
|
3.33 | $ 5.05 | -2.88 % | $ 313 M | ||
|
Harrow Health
HROW
|
2.67 | $ 47.49 | -0.86 % | $ 1.55 B | ||
|
China Pharma Holdings
CPHI
|
1 | $ 1.25 | - | $ 21.8 M | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.62 | 0.62 % | $ 402 M | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 6.75 | -3.3 % | $ 2.46 B | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.58 | -2.17 % | $ 3.37 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 3.64 | -3.96 % | $ 479 M | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 19.43 | 1.38 % | $ 899 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | $ 21.51 | 0.14 % | $ 2.05 B | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
Perrigo Company plc
PRGO
|
0.905 | $ 15.06 | 0.2 % | $ 2.07 B | ||
|
Aurora Cannabis
ACB
|
3.73 | $ 4.14 | -2.13 % | $ 86.3 M | ||
|
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 1.22 | 27.44 % | $ 28.5 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 3.33 | 1.06 % | $ 4.13 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
Tilray
TLRY
|
1.9 | $ 8.74 | -7.62 % | $ 5.4 B | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
0.502 | $ 0.65 | -0.68 % | $ 31.1 M | ||
|
Veru
VERU
|
6.39 | $ 2.53 | -5.95 % | $ 341 M | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 2.55 | 14.39 % | $ 26.6 M | ||
|
Viatris
VTRS
|
0.837 | $ 12.66 | -1.59 % | $ 15.3 B | ||
|
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | ||
|
cbdMD
YCBD
|
0.0863 | $ 0.83 | -9.94 % | $ 3.58 M |